The molecular clock mediates leptin-regulated bone formation

被引:468
作者
Fu, LN
Patel, MS
Bradley, A
Wagner, EF
Karsenty, G [1 ]
机构
[1] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA
[2] Baylor Coll Med, Bone Dis Program, Houston, TX 77030 USA
[3] Baylor Coll Med, Childrens Nutr Res Ctr, Houston, TX 77030 USA
[4] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England
[5] Res Inst Mol Pathol, A-1030 Vienna, Austria
基金
美国国家卫生研究院; 加拿大健康研究院;
关键词
D O I
10.1016/j.cell.2005.06.028
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The hormone leptin is a regulator of bone remodeling, a homeostatic function maintaining bone mass constant. Mice lacking molecular-clock components (Per and Cry), or lacking Per genes in osteoblasts, display high bone mass, suggesting that bone remodeling may also be subject to circadian regulation. Moreover, Per-deficient mice experience a paradoxical increase in bone mass following leptin intracerebroventricular infusion. Thus, clock genes may mediate the leptin-dependent sympathetic regulation of bone formation. We show that expression of clock genes in osteoblasts is regulated by the sympathetic nervous system and leptin. Clock genes mediate the antiproliferative function of sympathetic signaling by inhibiting G1 cyclin expression. Partially antagonizing this inhibitory loop, leptin also upregulates AP-1 gene expression, which promotes cyclin D1 expression, osteoblast proliferation, and bone formation. Thus, leptin determines the extent of bone formation by modulating, via sympathetic signaling, osteoblast proliferation through two antagonistic pathways, one of which involves the molecular clock.
引用
收藏
页码:803 / 815
页数:13
相关论文
共 36 条
[1]  
BENOVIC JL, 1988, ANNU REV CELL BIOL, V4, P405, DOI 10.1146/annurev.cellbio.4.1.405
[2]   Osteoclast differentiation and activation [J].
Boyle, WJ ;
Simonet, WS ;
Lacey, DL .
NATURE, 2003, 423 (6937) :337-342
[3]   Longevity and lineages: Toward the integrative biology of degenerative diseases in heart, muscle, and bone [J].
Chien, KR ;
Karsenty, G .
CELL, 2005, 120 (04) :533-544
[4]   Mouse α1(I)-collagen promoter is the best known promoter to drive efficient Cre recombinase expression in osteoblast [J].
Dacquin, R ;
Starbuck, M ;
Schinke, T ;
Karsenty, G .
DEVELOPMENTAL DYNAMICS, 2002, 224 (02) :245-251
[5]   Leptin inhibits bone formation through a hypothalamic relay: A central control of bone mass [J].
Ducy, P ;
Amling, M ;
Takeda, S ;
Priemel, M ;
Schilling, AF ;
Beil, FT ;
Shen, JH ;
Vinson, C ;
Rueger, JM ;
Karsenty, G .
CELL, 2000, 100 (02) :197-207
[6]   A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development [J].
Ducy, P ;
Starbuck, M ;
Priemel, M ;
Shen, JH ;
Pinero, G ;
Geoffroy, V ;
Amling, M ;
Karsenty, G .
GENES & DEVELOPMENT, 1999, 13 (08) :1025-1036
[7]   Leptin regulation of bone resorption by the sympathetic nervous system and CART [J].
Elefteriou, F ;
Ahn, JD ;
Takeda, S ;
Starbuck, M ;
Yang, XL ;
Liu, XY ;
Kondo, H ;
Richards, WG ;
Bannon, TW ;
Noda, M ;
Clement, K ;
Vaisse, C ;
Karsenty, G .
NATURE, 2005, 434 (7032) :514-520
[8]   Serum leptin level is a regulator of bone mass [J].
Elefteriou, F ;
Takeda, S ;
Ebihara, K ;
Magre, J ;
Patano, N ;
Kim, CA ;
Ogawa, Y ;
Liu, X ;
Ware, SM ;
Craigen, WJ ;
Robert, JJ ;
Vinson, C ;
Nakao, K ;
Capeau, J ;
Karsenty, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (09) :3258-3263
[9]   A rhythmic ror [J].
Emery, P ;
Reppert, SM .
NEURON, 2004, 43 (04) :443-446
[10]   The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo [J].
Fu, LN ;
Pelicano, H ;
Liu, JS ;
Huang, P ;
Lee, CC .
CELL, 2002, 111 (01) :41-50